Validus Holdings, Ltd. (NYSE:VR) CEO Lixin Zeng sold 26,136 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $52.10, for a total transaction of $1,361,685.60. Following the completion of the transaction, the chief executive officer now owns 57,855 shares of the company’s stock, valued at approximately $3,014,245.50. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Shares of Validus Holdings, Ltd. (VR) traded down $0.04 during trading hours on Friday, reaching $52.42. 634,200 shares of the company were exchanged, compared to its average volume of 605,394. Validus Holdings, Ltd. has a 1 year low of $41.15 and a 1 year high of $58.76. The company has a quick ratio of 0.95, a current ratio of 0.95 and a debt-to-equity ratio of 0.52.
Validus Holdings (NYSE:VR) last issued its earnings results on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($3.30) by $0.08. The firm had revenue of $407.00 million during the quarter, compared to analysts’ expectations of $453.04 million. Validus Holdings had a negative net margin of 1.38% and a negative return on equity of 0.49%. The firm’s revenue for the quarter was up 24.3% compared to the same quarter last year. During the same period last year, the firm posted $1.02 earnings per share. sell-side analysts anticipate that Validus Holdings, Ltd. will post -0.06 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be given a $0.38 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $1.52 annualized dividend and a dividend yield of 2.90%. Validus Holdings’s dividend payout ratio (DPR) is presently -233.84%.
Several research analysts have recently issued reports on VR shares. Zacks Investment Research cut shares of Validus Holdings from a “hold” rating to a “strong sell” rating in a report on Thursday, September 28th. UBS AG decreased their price objective on shares of Validus Holdings from $50.00 to $48.00 and set a “neutral” rating for the company in a report on Monday, October 2nd. TheStreet cut shares of Validus Holdings from a “b” rating to a “c+” rating in a report on Wednesday, October 11th. ValuEngine upgraded shares of Validus Holdings from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Finally, BidaskClub cut shares of Validus Holdings from a “sell” rating to a “strong sell” rating in a report on Friday, August 18th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company. Validus Holdings currently has a consensus rating of “Hold” and an average price target of $54.83.
Several large investors have recently modified their holdings of VR. IFP Advisors Inc lifted its position in shares of Validus Holdings by 14.0% in the 2nd quarter. IFP Advisors Inc now owns 2,154 shares of the insurance provider’s stock valued at $112,000 after acquiring an additional 265 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Validus Holdings in the 2nd quarter valued at approximately $116,000. The Manufacturers Life Insurance Company lifted its position in shares of Validus Holdings by 10.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock valued at $124,000 after acquiring an additional 219 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of Validus Holdings by 93.7% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock valued at $138,000 after acquiring an additional 1,282 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Validus Holdings by 10.6% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,905 shares of the insurance provider’s stock valued at $151,000 after acquiring an additional 278 shares in the last quarter. Institutional investors and hedge funds own 92.74% of the company’s stock.
Validus Holdings Company Profile
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus Holdings Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.